Table 4. Trials evaluating targeted therapies in BRAF‐mutant non‐small cell lung cancer.
Abbreviations: BRAF, B‐Raf proto‐oncogene, serine/threonine kinase; CSF‐1, colony stimulating factor 1; ERK, extracellular signal‐regulated kinase; MEK, mitogen‐activated protein kinase kinase.